Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4APP

Crystal Structure of the Human p21-Activated Kinase 4 in Complex with (S)-N-(5-(3-benzyl-1-methylpiperazine-4-carbonyl)-6,6-dimethyl-1,4,5, 6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-phenoxybenzamide

Summary for 4APP
Entry DOI10.2210/pdb4app/pdb
Related2BVA 2CDZ 2J0I 2X4Z
DescriptorSERINE/THREONINE-PROTEIN KINASE PAK 4, N-[6,6-dimethyl-5-[(2S)-4-methyl-2-(phenylmethyl)piperazin-1-yl]carbonyl-2,4-dihydropyrrolo[3,4-c]pyrazol-3-yl]-3-phenoxy-benzamide, GLYCEROL, ... (4 entities in total)
Functional Keywordstransferase, protein kinase
Biological sourceHOMO SAPIENS (HUMAN)
Total number of polymer chains1
Total formula weight34081.61
Authors
Primary citationGuo, C.,Mcalpine, I.,Zhang, J.,Knighton, D.D.,Kephart, S.,Johnson, M.C.,Li, H.,Bouzida, D.,Yang, A.,Dong, L.,Marakovits, J.,Tikhe, J.,Richardson, P.,Guo, L.C.,Kania, R.,Edwards, M.P.,Kraynov, E.,Christensen, J.,Piraino, J.,Lee, J.,Dagostino, E.,Del-Carmen, C.,Deng, Y.L.,Smeal, T.,Murray, B.W.
Discovery of Pyrroloaminopyrazoles as Novel Pak Inhibitors.
J.Med.Chem., 55:4728-, 2012
Cited by
PubMed Abstract: The P21-activated kinases (PAK) are emerging antitumor therapeutic targets. In this paper, we describe the discovery of potent PAK inhibitors guided by structure-based drug design. In addition, the efflux of the pyrrolopyrazole series was effectively reduced by applying multiple medicinal chemistry strategies, leading to a series of PAK inhibitors that are orally active in inhibiting tumor growth in vivo.
PubMed: 22554206
DOI: 10.1021/JM300204J
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

238268

数据于2025-07-02公开中

PDB statisticsPDBj update infoContact PDBjnumon